| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/02/2001 | US6167759 Ultrasonic system for grading meat |
| 01/02/2001 | US6167748 Capacitively readout multi-element sensor array with common-mode cancellation |
| 01/02/2001 | US6167746 Apparatus and method for determining a person's sobriety |
| 01/02/2001 | US6167710 Ice seeding apparatus for cryopreservation systems |
| 01/02/2001 | CA2194957C Method and apparatus for on-line measurement of pulp fibre surface development |
| 01/02/2001 | CA2119816C Test strip analysis system |
| 01/02/2001 | CA2067724C Disposable diagnostic assembly |
| 01/02/2001 | CA2019218C Magnetic protein conjugates, a process for the preparation thereof and the use thereof |
| 01/02/2001 | CA2018323C Analytical assays by noncentrifugal and noncapillary manipulations |
| 01/02/2001 | CA2007336C Diagnostic test using chimeric antibodies |
| 12/30/2000 | CA2312631A1 5ht1 receptor agonists, caffeine and either a cox-2 inhibitor or nsaid for the treatment of migraine |
| 12/30/2000 | CA2277089A1 Method for measuring de novo t-cell production in humans |
| 12/29/2000 | WO2001001128A1 Method for measuring the gerontological value of biologically active substances and compositions, mainly food and cosmetic products |
| 12/28/2000 | WO2000079284A1 Cartilage resorption assays |
| 12/28/2000 | WO2000079283A1 Dehydration/rehydration of marked liposomes on a test device |
| 12/28/2000 | WO2000079282A1 Chemiluminescence redox assay to quantify analytes in biological samples |
| 12/28/2000 | WO2000079281A1 Extracellular camp-dependent protein kinase in diagnosis, prognosis and treatment of cancer |
| 12/28/2000 | WO2000079279A1 Quantitative chromatographic measuring device and method for manufacturing the same |
| 12/28/2000 | WO2000079278A1 Chromatographic analyzer |
| 12/28/2000 | WO2000079277A1 NEW ATPase ASSAY |
| 12/28/2000 | WO2000079276A1 Method for conducting chemiluminescent binding assay |
| 12/28/2000 | WO2000079275A1 Diagnostics and remedies for diseases with participation of macrocytes/macrophages |
| 12/28/2000 | WO2000079274A2 Methods for assaying subcellular conditions using energy transfer |
| 12/28/2000 | WO2000079273A2 Methods and device for in vitro detection and characterization of psychoactives using analysis of repetitive electrical activity in a neuronal sample |
| 12/28/2000 | WO2000079270A1 Methods for profiling and manufacturing tissue using a database that includes indices representative of a tissue population |
| 12/28/2000 | WO2000079269A1 Methods for profiling and classifying tissue using a database that includes indices representative of a tissue population |
| 12/28/2000 | WO2000079268A2 Method and apparatus for assaying a drug candidate to estimate a pharmacokinetic parameter associated therewith |
| 12/28/2000 | WO2000079265A1 Method for the analysis of a nutritive product |
| 12/28/2000 | WO2000079262A1 Device for measuring a carbon monoxide content |
| 12/28/2000 | WO2000079260A1 Capillary electrophoresis method for screening for affinity ligands using a detectable competitive ligand |
| 12/28/2000 | WO2000079256A1 Method and apparatus for measuring water content |
| 12/28/2000 | WO2000079252A1 Method and apparatus for x-ray diffraction analyses |
| 12/28/2000 | WO2000079243A1 Multiple sensing system and device |
| 12/28/2000 | WO2000079241A2 A system for cell-based screening |
| 12/28/2000 | WO2000079009A2 Improved primers and methods for the detection and discrimination of nucleic acids |
| 12/28/2000 | WO2000079008A2 High throughput assay system |
| 12/28/2000 | WO2000079005A1 High efficiency methods for combined immunocytochemistry and in-situ hybridization |
| 12/28/2000 | WO2000079004A1 2'-fluoropyrimidine anti-calf intestinal phosphatase nucleic acid ligands |
| 12/28/2000 | WO2000078999A1 Method of pretreatment of sample for quantitating cholesterol and method for quantitating cholesterol in specific lipoproteins by using the same |
| 12/28/2000 | WO2000078996A1 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids |
| 12/28/2000 | WO2000078992A2 Mass transport limited in vivo analyte sensor |
| 12/28/2000 | WO2000078991A2 Process for removing systematic error and outlier data and for estimating random error in chemical and biological assays |
| 12/28/2000 | WO2000078972A2 Regulation with binding cassette transporter protein abc1 |
| 12/28/2000 | WO2000078971A2 Atp binding cassette transporter protein abc1 popypeptides |
| 12/28/2000 | WO2000078970A1 Nucleic and proteinic acids corresponding to human gene abc1 |
| 12/28/2000 | WO2000078966A1 Groups of borrelia burgdorferi and borrelia afzelii that cause lyme disease in humans |
| 12/28/2000 | WO2000078955A1 Epithelial cell growth inhibitors |
| 12/28/2000 | WO2000078954A2 Human transcriptional regulator proteins |
| 12/28/2000 | WO2000078953A2 Human transport proteins |
| 12/28/2000 | WO2000078952A2 Human rna metabolism proteins (rmep) |
| 12/28/2000 | WO2000078947A1 Head trauma induced cytoplasmatic calcium binding protein |
| 12/28/2000 | WO2000078942A1 Non-destructive cell-based assay |
| 12/28/2000 | WO2000078941A2 Methods and products for manipulating uncoupling protein expression |
| 12/28/2000 | WO2000078940A1 In vivo insect model system for type-2 diabetes |
| 12/28/2000 | WO2000078933A2 Novel calpains and their use |
| 12/28/2000 | WO2000078930A1 Method for enhancing hematopoiesis |
| 12/28/2000 | WO2000078919A1 Method and apparatus for the detection of volatile products in a sample |
| 12/28/2000 | WO2000078917A1 Device and method for analyzing a biologic sample |
| 12/28/2000 | WO2000078807A1 Purified antigen for alzheimer's disease, and methods of obtaining and using same |
| 12/28/2000 | WO2000078805A1 Peptide having preptin functionality |
| 12/28/2000 | WO2000078802A2 Secreted polypeptides and corresponding polynucleotides |
| 12/28/2000 | WO2000078763A2 Non-hydrolyzable analogs of heroin metabolites suitable for use in immunoassay |
| 12/28/2000 | WO2000078455A1 Devices and methods for the performance of miniaturized in vitro amplification assays |
| 12/28/2000 | WO2000078452A1 Device for implementing an analysis pack, analysis pack and method using same |
| 12/28/2000 | WO2000078445A1 Methods and apparatus for performing array microcrystallizations |
| 12/28/2000 | WO2000078362A2 Stable, radioactively marked nanoparticles, method for the production and utilization thereof |
| 12/28/2000 | WO2000078361A2 Methods of imaging and targeting tumor vasculature |
| 12/28/2000 | WO2000078344A1 Prion protein peptides and uses thereof |
| 12/28/2000 | WO2000078330A2 Adenosine diphosphatase and activators thereof and their medical uses |
| 12/28/2000 | WO2000078214A1 Blood sampling device |
| 12/28/2000 | WO2000078210A1 Characteristic monitor system for use with analyte sensor |
| 12/28/2000 | WO2000078204A2 Methods for remote characterization of an odor |
| 12/28/2000 | WO2000058460A3 Casb619 involved in colon cancers |
| 12/28/2000 | WO2000053735A3 Methods for identifying modulators of synaptic plasticity and cell motility |
| 12/28/2000 | WO2000049623A3 Method and device for liberating oxygen isotopes from oxygen-containing solids |
| 12/28/2000 | WO2000049162A3 Compositions and methods for non-targeted activation of endogenous genes |
| 12/28/2000 | WO2000046344A3 Non-stochastic generation of genetic vaccines and enzymes |
| 12/28/2000 | WO2000046343A3 Screening assay for antagonists of fgfr-mediated malignant cell transformation and tumor formation |
| 12/28/2000 | WO2000045851A3 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin |
| 12/28/2000 | WO2000043495A3 33 human secreted proteins |
| 12/28/2000 | WO2000040593A3 Target molecule attachment to surfaces |
| 12/28/2000 | WO2000037640A3 Compositions and methods for the treatment of tumor |
| 12/28/2000 | WO2000034474A3 Growth factor homolog zvegf3 |
| 12/28/2000 | WO2000032776A3 Secreted amd transmembrane polypeptides and nucleic acids encoding the same |
| 12/28/2000 | WO2000030667A3 Compositions and methods using lactadherin or variants thereof |
| 12/28/2000 | WO2000017369B1 Alzheimer's disease secretase |
| 12/28/2000 | DE19929072A1 Vorrichtung zur Prüfung von Rohrleitungen aus ferromagnetischen Materialien Device for inspecting conduits made of ferromagnetic materials |
| 12/28/2000 | DE19928496A1 Stabile radioactively-marked nanoparticles bound to other molecules for use in medical and diagnostic techniques, particularly used for studying phagocyte processes |
| 12/28/2000 | DE19913940C1 Highly sensitive detection of proteins separated on a gel, by on-gel reaction with biotinylating reagent, then detecting the bound reagent |
| 12/28/2000 | CA2783140A1 Srsv detection kit |
| 12/28/2000 | CA2388689A1 Characteristic monitor system for use with analyte sensor |
| 12/28/2000 | CA2386393A1 Purified antigen for alzheimer's disease, and methods of obtaining and using same |
| 12/28/2000 | CA2377707A1 Improved primers and methods for the detection and discrimination of nucleic acids |
| 12/28/2000 | CA2377648A1 Prion protein peptides and uses thereof |
| 12/28/2000 | CA2377263A1 Polynucleotides and polypeptides encoded thereby |
| 12/28/2000 | CA2377188A1 Methods of imaging and targeting tumor vasculature |
| 12/28/2000 | CA2376782A1 Device for implementing an analysis pack, analysis pack and method using same |
| 12/28/2000 | CA2375911A1 2'-fluoropyrimidine anti-calf intestinal phosphatase nucleic acid ligands |
| 12/28/2000 | CA2375905A1 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids |
| 12/28/2000 | CA2375890A1 Process for removing systematic error and outlier data and for estimating random error in chemical and biological assays |